Hôpital Ruber Internacional
Le professeur Galceran dirige l'unité génito-urinaire et des sarcomes à Vall d'Hebron – le plus grand expert espagnol de l'ostéosarcome avec plus de 1 100 traitements effectués.
Le Dr Graupera dirige le département d'hématologie-oncologie de Sant Joan De Déu, l'un des meilleurs hôpitaux pédiatriques d'Europe. Ses recherches portent sur les cancers pédiatriques, notamment l'ostéosarcome.
Le médecin est un oncologue pédiatrique avec 37 ans d'expérience, spécialisé dans le traitement des troubles sanguins et la réalisation de procédures telles que les greffes de moelle osseuse et la thérapie par ablation. Le médecin est actuellement chef du service d'hémato-oncologie pédiatrique à l'Hôpital universitaire Quironsalud Madrid.<\/p>
Avec un dossier académique prolifique, le médecin a édité 14 livres, contribué à 75 chapitres de livres et présenté à plus de 200 conférences. Le médecin est membre de plusieurs associations professionnelles, y compris l'Association espagnole d'hématologie pédiatrique et l'Association espagnole d'oncologie pédiatrique.<\/p>
Le médecin traite un large éventail de conditions, y compris la leucémie, le lymphome, le myélome multiple et divers troubles hématologiques et auto-immuns.<\/p>
Spain follows a multimodal protocol for osteosarcoma overseen by the Spanish Group for Research on Sarcomas (GEIS). The standard framework includes neoadjuvant chemotherapy, limb-salvage surgery, and adjuvant chemotherapy. Specialist centers like Clinica Universidad de Navarra report exceptional 95% limb preservation rates using these protocols.
Bookimed Expert Insight: Data from top-tier Spanish institutions shows that surgical volume directly correlates with limb-sparing success. Clinica Universidad de Navarra, which has treated over 700,000 patients globally, maintains a 74% cure rate for bone sarcomas. This is significantly higher than general oncology averages. Patients should prioritize centers like this or SJD Barcelona Children's Hospital, where Dr. Jaume Mora Graupera applies specialized pediatric molecular pathology to refine chemotherapy dosing.
Patient Consensus: Patients note it's important to confirm the team includes a specialized orthopedic oncologist rather than a general surgeon. Families emphasize that securing a second opinion on the initial biopsy is the most critical early step to avoid misdiagnosis.
Spain designates centers of excellence for osteosarcoma through the CSUR national accreditation system. Leading institutions include Clinica Universidad de Navarra, which reports a 74% cure rate for bone sarcomas. SJD Barcelona Children's Hospital is globally recognized for specialized pediatric orthopedic oncology.
Bookimed Expert Insight: While many choose large public centers, private JCI-accredited facilities offer unique advantages for limb preservation. Clinica Universidad de Navarra manages over 140,000 patients annually and maintains a 95% limb-salvage rate. This highlights the value of choosing a center that integrates orthopedic oncology with specialized reconstructive care.
Patient Consensus: Patients emphasize the importance of choosing a large tertiary center over local hospitals. They note that having a dedicated multidisciplinary tumor board helps speed up the biopsy and treatment process.
Advanced osteosarcoma treatment in Spain focuses on limb-preserving surgery and high-dose multi-agent chemotherapy. Leading centers utilize custom endoprosthesis replacement and rotationplasty to maintain mobility. Specialized clinics also integrate Gamma Knife radiosurgery and clinical trials for metastatic cases. Highly experienced multidisciplinary teams manage complex tumor resections and lung metastasectomy.
Bookimed Expert Insight: Spain holds a unique advantage in bone sarcoma care with a documented 74% cure rate at specialized centers like Clinica Universidad de Navarra. This performance stems from high surgical volumes and the integration of research into clinical practice. Patients should look for centers with dedicated molecular medicine laboratories to refine diagnostic accuracy.
Patient Consensus: Patients note that having a dedicated coordinator is helpful for navigating intensive chemotherapy schedules and follow-up scans. They emphasize that professional support during lung surgery for metastatic spread makes the process manageable.
Bookimed Expert Insight: 西班牙顶级中心的骨肉瘤治愈率可达74%，且肢体保全率高达95%。例如纳瓦拉大学医院的系统化评估模式，这对于该技术的成功至关重要。患者在选择时应查看医院每年的手术量数据，而不仅仅是其综合排名。
Patient Consensus: 患者强调治疗中心对于罕见骨癌的专注度远比名气重要。许多人建议在进行活检前寻求第二意见，因为不当的初期操作可能会增加后续手术的难度。
Language barriers in Spain are minimal at top private oncology centers. Most leading specialists at hospitals like Centro Medico Teknon or Clinica Universidad de Navarra are fluent in English. These facilities often provide dedicated international departments and coordinators to assist with translations and scheduling logistics.
Bookimed Expert Insight: While doctors at high-volume centers like Clínica Universidad de Navarra serve patients from 70 countries, support staff may only speak Spanish. Patients should prioritize clinics with dedicated international departments. These teams act as essential bridges between the patient and the nursing or administrative staff. This is vital for complex osteosarcoma care where 74% cure rates rely on precise follow-up protocols.
Patient Consensus: Patients emphasize having written instructions for chemotherapy doses and side effects. They note that while specialists are fluent, having a dedicated coordinator helps manage logistics with pharmacies and ward nurses.
International patients traveling to Spain for medical care typically require a short-stay Schengen Visa (Type C) for visits under 90 days. For long-term oncology treatments like osteosarcoma, a national long-stay visa is necessary. You must provide a formal hospital letter from a JCI-accredited facility and proof of funds.
Bookimed Expert Insight: Spain ranks highly for complex sarcoma care, with Clinica Universidad de Navarra reporting a 74% bone sarcoma cure rate. While specialized oncology visas do not exist, clinics like Centro Médico Teknon or Quironsalud Madrid provide the specific administrative paperwork required by consulates to justify long-term residency for limb-preservation surgeries and advanced radiation therapy.
Patient Consensus: Patients note it is essential to coordinate closely with the hospital's international department to get the exact letter format Spanish consulates expect. They emphasize having all funding proof ready since standard travel insurance rarely covers oncology costs.
International health insurance covers oncology care in Spain if the condition was not diagnosed before the policy started. Premium plans usually include chemotherapy, radiotherapy, and surgery at JCI-accredited private hospitals. Patients with pre-existing conditions may face exclusions or require specialized underwriting with waiting periods.
Bookimed Expert Insight: Spain’s oncology market is highly specialized. Clinica Universidad de Navarra reports a 74% cure rate for bone sarcomas. Patients should choose clinics with high-volume surgical teams. Dr. Joan Carles Galceran at Centro Médico Teknon has treated over 1,200 patients. Large networks like HM Hospitales manage 2.3 million outpatients yearly. This volume ensures insurers are familiar with their billing protocols.
Patient Consensus: Dealing with high-complexity cases like osteosarcoma is easier with a dedicated coordinator. Parents note that having local support helps manage logistics when treating children abroad.